Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells

Journal of Virology

Volumn 82, Issue 10, 2008, Pages 4946-4954

  Whalen, Kerry A ^a,d   Weber, Georg F ^b   Benjamin, Thomas L ^c   Schaffhausen, Brian S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR PEA3; VIRUS MIDDLE T ANTIGEN; LUCIFERASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VIRUS T ANTIGEN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL TRANSFORMATION; EMBRYO; ENHANCER REGION; EXTRACELLULAR SPACE; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS VIRULENCE; WOUND; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE FUSION; GENETICS; METABOLISM; PHYSIOLOGY; REPORTER GENE;

MURINE POLYOMAVIRUS; POLYOMAVIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ARTIFICIAL GENE FUSION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION PROFILING; GENES, REPORTER; LUCIFERASES; MICE; OSTEOPONTIN; POLYOMAVIRUS; PROMOTER REGIONS (GENETICS); RNA, ANTISENSE;

EID: 43249087639     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02650-07     Document Type: Article

References (105)

1. Akino, K., A. Ohtsuru, K. Kanda, A. Yasuda, T. Yamamoto, Y. Akino, S. Naito, M. Kurokawa, N. Iwahori, and S. Yamashita. 2000. Parathyroid hormone-related peptide is a potent tumor angiogenic factor. Endocrinology 141:4313-4316.
2. Andrews, D. W., J. Gupta, and G. Abisdris. 1993. Evidence that the middle T antigen of polyomavirus interacts with the membrane skeleton. Mol. Cell. Biol. 13:4703-4713.
3. Arai, A., E. Kanda, and O. Miura. 2002. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene 21:2641-2651.
4. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Janssen, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860-864.
5. Bautch, V. L., S. Toda, J. A. Hassell, and D. Hanahan. 1987. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell 51:529-537.
6. Bidder, M., J. S. Shao, N. Charlton-Kachigian, A. P. Loewy, C. F. Semenkovich, and D. A. Towler. 2002. Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities. J. Biol. Chem. 277:44485-44496.
7. Bronson, R., C. Dawe, J. Carroll, and T. Benjamin. 1997. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc. Natl. Acad. Sci. USA 94:7954-7958.
8. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle T antigen interacts with SHC via the NPTY (Asn-Pro-Thr-Tyr) motif in middle T. Proc. Natl. Acad. Sci. USA 91:6344-6348.
9. Carmichael, G., B. Schaffhausen, D. Dorsky, D. Oliver, and T. Benjamin. 1982. The role of the carboxy terminus of middle T antigen of polyoma virus. Proc. Natl. Acad. Sci. USA 79:3579-3583.
10. Carmichael, G., B. S. Schaffhausen, G. Mandel, T. J. Liang, and T. L. Benjamin. 1984. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 81:679-683.
11. Chen, C. A., and H. Okayama. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6:632-637.
12. Chen, L., X. Wang, and M. M. Fluck. 2006. Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J. Virol. 80:7295-7307.
13. Chen, M. C., D. Redenius, F. Osati-Ashtiani, and M. M. Fluck. 1995. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication. J. Virol. 69:326-333.
14. Chen, Y., and S. R. Rittling. 2003. Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing. Clin. Exp. Metastasis 20:111-120.
15. Cheng, S. H., R. Harvey, P. C. Espino, K. Semba, T. Yamamoto, K. Toyoshima, and A. E. Smith. 1988. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J. 7:3845-3855.
16. Coffer, P., M. de Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, and W. Kruijer. 1994. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9:911-921.
17. Courtneidge, S., and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439.
18. Culleré, X., P. Rose, U. Thathamangalam, A. Chatterjee, K. P. Mullane, D. C. Pallas, T. L. Benjamin, T. M. Roberts, and B. S. Schaffhausen. 1998. Serine 257 phosphorylation regulates association of polyomavirus middle T antigen with 14-3-3 proteins. J. Virol. 72:558-565.
19. Czuwara-Ladykowska, J., V. I. Sementchenko, D. K. Watson, and M. Trojanowska. 2002. Ets1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J. Biol. Chem. 277:20399-20408.
20. Dahl, J., A. Jurczak, L. A. Cheng, D. C. Baker, and T. L. Benjamin. 1998. Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J. Virol. 72:3221-3226.
21. Dawe, C. J., R. Freund, G. Mandel, K. Ballmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:243-261.
22. Denhardt, D. T., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB J. 7:1475-1482.
23. Denhardt, D. T., C. A. Lopez, E. E. Rollo, S. M. Hwang, X. R. An, and S. E. Walther. 1995. Osteopontin-induced modifications of cellular functions. Ann. N. Y. Acad. Sci. 760:127-142.
24. Dilworth, S. M., C. E. Brewster, M. D. Jones, L. Lanfrancone, G. Pelicci, and P. G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367:87-90.
25. Dittmer, J. 2003. The biology of the Ets1 proto-oncogene. Mol. Cancer 2:29.
26. 1: evidence for the involvement of transcription factor Ets1. J. Virol. 67:6087-6095.
27. Druker, B. J., L. E. Ling, B. Cohen, T. M. Roberts, and B. S. Schaffhausen. 1990. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. J. Virol. 64:4454-4461.
28. Druker, B. J., L. Sibert, and T. M. Roberts. 1992. Polyomavirus middle T-antigen NPTY mutants. J. Virol. 66:5770-5776.
29. Eddy, B. 1969. Polyoma virus. Virol. Monogr. 7:1-114.
30. El-Tanani, M., R. Barraclough, M. C. Wilkinson, and P. S. Rudland. 2001. Metastasis-inducing DNA regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. Cancer Res. 61:5619-5629.
31. El-Tanani, M., A. Platt-Higgins, P. S. Rudland, and F. C. Campbell. 2004. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J. Biol. Chem. 279:20794- 20806.
32. El-Tanani, M. K., R. Barraclough, M. C. Wilkinson, and P. S. Rudland. 2001. Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene 20:1793-1797.
33. Fluck, M. M., and S. Z. Haslam. 1996. Mammary tumors induced by polyomavirus. Breast Cancer Res. Treat. 39:45-56.
34. Freund, R., C. J. Dawe, J. P. Carroll, and T. L. Benjamin. 1992. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am. J. Pathol. 141:1409-1425.
35. Freund, R., A. Sotnikov, R. T. Bronson, and T. L. Benjamin. 1992. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191:716-723.
36. Guo, X., Y. P. Zhang, D. A. Mitchell, D. T. Denhardt, and A. F. Chambers. 1995. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol. 15:476-487.
37. Gutierrez-Hartmann, A., D. L. Duval, and A. P. Bradford. 2007. ETS transcription factors in endocrine systems. Trends Endocrinol. Metab. 18:150-158.
38. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
39. Harvey, R., B. A. Oostra, G. J. Belsham, P. Gillett, and A. E. Smith. 1984. An antibody to a synthetic peptide recognizes polyomavirus middle-T antigen and reveals multiple in vitro tyrosine phosphorylation sites. Mol. Cell. Biol. 4:1334-1342.
40. Holman, P. S., O. V. Gjoerup, T. Davin, and B. S. Schaffhausen. 1994. Characterization of an immortalizing N-terminal domain of polyomavirus large T antigen. J. Virol. 68:668-673.
41. Hong, Y. K., A. Mikami, B. Schaffhausen, T. Jun, and T. M. Roberts. 2003. A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site. Proc. Natl. Acad. Sci. USA 100:9434-9439.
42. fyn with middle tumor antigen in murine polyomavirus-transformed rat cells. J. Virol. 63:2343-2347.
43. Hu, Q., A. Klippel, A. J. Muslin, W. J. Fantl, and L. T. Williams. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100-102.
44. Hunter, T., M. A. Hutchinson, and W. Eckhart. 1984. Polyoma middle-T antigen can be phosphorylated on tyrosine at multiple sites in vitro. EMBO J. 3:73-80.
45. Hwang, S. M., C. A. Lopez, D. E. Heck, C. R. Gardner, D. L. Laskin, J. D. Laskin, and D. T. Denhardt. 1994. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 269:711-715.
46. Ito, Y. 1979. Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation. Virology 98:261-266.
47. Jessen, K. A., S. Y. Liu, C. G. Tepper, J. Karrim, E. T. McGoldrick, A. Rosner, R. J. Munn, L. J. Young, A. D. Borowsky, R. D. Cardiff, and J. P. Gregg. 2004. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res. 6:R157-R169.
48. Ji, Z., C. Degerny, N. Vintonenko, J. Deheuninck, B. Foveau, C. Leroy, J. Coll, D. Tulasne, J. L. Baert, and V. Fafeur. 2007. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 26:395-406.
49. Kaplan, D. R., M. Whitman, B. Schaffhausen, L. Raptis, R. L. Garcea, D. Pallas, T. M. Roberts, and L. Cantley. 1986. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc. Natl. Acad. Sci. USA 83:3624-3628.
50. Kazanecki, C. C., D. J. Uzwiak, and D. T. Denhardt. 2007. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J. Cell. Biochem. 102:912-924.
51. Klucky, B., B. Koch, M. Radolf, P. Steinlein, and E. Wintersberger. 2004. Polyomavirus tumorantigens have a profound effect on gene expression in mouse fibroblasts. Oncogene 23:4707-4721.
52. Kornbluth, S., M. Sudol, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature 325:171-173.
53. Kurpios, N. A., N. A. Sabolic, T. G. Shepherd, G. M. Fidalgo, and J. A. Hassell. 2003. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 8:177-190.
54. Lammi, J., J. Huppunen, and P. Aarnisalo. 2004. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol. Endocrinol. 18:1546-1557.
55. Lewis, B. C., D. S. Klimstra, and H. E. Varmus. 2003. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 17:3127-3138.
56. Malyankar, U. M., R. Hanson, S. M. Schwartz, A. L. Ridall, and C. M. Giachelli. 1999. Upstream stimulatory factor 1 regulates osteopontin expression in smooth muscle cells. Exp. Cell Res. 250:535-547.
57. Markland, W., B. A. Oostra, R. Harvey, A. F. Markham, W. H. Colledge, and A. E. Smith. 1986. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. J. Virol. 59:384-391.
58. Martin, M., J. Piette, M. Yaniv, W. Tang, and W. Folk. 1988. Activation of the polyomavirus enhancer by a murine activator protein1 (AP1) homolog and two contiguous proteins. Proc. Natl. Acad. Sci. USA 85:5839-5843.
59. Meili, R., P. Cron, B. Hemmings, and K. Ballmer-Hofer. 1998. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism. Oncogene 16:903-907.
60. Mullane, K. P., M. Ratnofsky, X. Culleré, and B. Schaffhausen. 1998. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol. Cell. Biol. 18:7556-7564.
61. Naito, S., K. Shimizu, M. Nakashima, T. Nakayama, T. Ito, M. Ito, S. Yamashita, and I. Sekine. 2000. Overexpression of Ets-1 transcription factor in angiosarcoma of the skin. Pathol. Res. Pract. 196:103-109.
62. Oates, A. J., R. Barraclough, and P. S. Rudland. 1996. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13:97-104.
63. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
64. Paumelle, R., D. Tulasne, Z. Kherrouche, S. Plaza, C. Leroy, S. Reveneau, B. Vandenbunder, V. Fafeur, and D. Tulashe. 2002. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21:2309-2319.
65. Rittling, S. R., and A. F. Chamhers. 2004. Role of osteopontin in tumour progression. Br. J. Cancer 90:1877-1881.
66. Rochford, R., C. T. Davis, K. K. Yoshimoto, and L. P. Villarreal. 1990. Minimal subenhancer requirements for high-level polyomavirus DNA replication: a cell-specific synergy of PEA3 and PEA1 sites. Mol. Cell. Biol. 10:4996-5001.
67. Sato, M., E. Morii, T. Komori, H. Kawahata, M. Sugimoto, K. Terai, H. Shimizu, T. Yasui, H. Ogihara, N. Yasui, T. Ochi, Y. Kitamura, Y. Ito, and S. Nomura. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17: 1517-1525.
68. Schaffhausen, B., and T. L. Benjamin. 1981. Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro. J. Virol. 40:184-196.
69. Schaffhausen, B. S., H. Dorai, G. Arakere, and T. L. Benjamin. 1982. Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity. Mol. Cell. Biol. 2:1187-1198.
70. Seidel, J. J., and B. J. Graves. 2002. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev. 16:127-137.
71. Sementchenko, V. I., and D. K. Watson. 2000. Ets target genes: past, present and future. Oncogene 19:6533-6548.
72. Seth, A., and T. S. Papas. 1990. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene 5:1761-1767.
73. Seth, A., and D. K. Watson. 2005. ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer 41:2462-2478.
74. Shepherd, T. G., L. Kockeritz, M. R. Szrajber, W. J. Muller, and J. A. Hassell. 2001. The pca3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr. Biol. 11:1739-1748.
75. Silver, J., B. Schaffhausen, and T. Benjamin. 1978. Tumor antigens induced by nontransforming mutants of polyoma virus. Cell 15:485-496.
76. Su, L., A. B. Mukherjee, and B. B. Mukherjee. 1995. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 10:2163-2169.
77. Su, W., W. Liu, B. Schaffhausen, and T. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270:12331-12335.
78. Tehranian, A., D. W. Morris, B. H. Min, D. J. Bird, R. D. Cardiff, and P. A. Barry. 1996. Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. Am. J. Pathol. 149:1177-1191.
79. Templeton, D., and W. Eckhart. 1982. Mutation causing premature termination of the polyoma virus middle T antigen blocks cell transformation. J. Virol. 41:1014-1024.
80. Tezuka, K., D. T. Denhardt, G. A. Rodan, and S. Harada. 1996. Stimulation of mouse osteopontin promoter by v-Src is mediated by a CCAAT box-binding factor. J. Biol. Chem. 271:22713-22717.
81. Treisman, R., U. Novak, J. Favaloro, and R. Kamen. 1981. Transformation of rat cells by an altered polyoma virus genome expressing only the middle T protein. Nature 292:595-600.
82. Tuck, A. B., D. M. Arsenault, F. P. O'Malley, C. Hota, M. C. Ling, S. M. Wilson, and A. F. Chambers. 1999. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 18:4237-4246.
83. Tuck, A. B., B. E. Elliott, C. Hota, E. Tremblay, and A. F. Chambers. 2000. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J. Cell. Biochem. 78:465-475.
84. Urich, M., M. Y. el Shemerly, D. Besser, Y. Nagamine, and K. Ballmer-Hofer. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
85. Urich, M., M. Senften, P. E. Shaw, and K. Ballmer-Hofer. 1997. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation. Oncogene 14:1235-1241.
86. Utermark, T., B. S. Schaffhausen, T. M. Roberts, and J. J. Zhao. 2007. The p110α isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation. J. Virol. 81:7069-7076.
87. Vanacker, J. M., C. Delmarre, X. Guo, and V. Laudet. 1998. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ. 9:1007-1014.
88. Vary, C. P., V. Li, A. Raouf, R. Kitching, I. Kola, C. Franceschi, M. Venanzoni, and A. Seth. 2000. Involvement of Ets transcription factors and targets in osteoblast differentiation and matrix mineralization. Exp. Cell Res. 257:213-222.
89. Wai, P. Y., and P. C. Kuo. 2004. The role of Osteopontin in tumor metastasis. J. Surg. Res. 121:228-241.
90. Walter, G., R. Ruediger, C. Slaughter, and M. Mumby. 1990. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:2521-2525.
91. Wang, D., S. Yamamoto, N. Hijiya, E. N. Benveniste, and C. L. Gladson. 2000. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 19:5801-5809.
92. Wasylyk, B., C. Wasylyk, P. Flores, A. Begue, D. Leprince, and D. Stehelin. 1990. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346:191-193.
93. Wasylyk, C., A. P. Bradford, A. Gutierrez-Hartmann, and B. Wasylyk. 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899-913.
94. Wasylyk, C., P. Flores, A. Gutman, and B. Wasylyk. 1989. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J. 8:3371-3378.
95. Weber, G. F., B. Adler, and S. Ashkar. 1999. Osteopontin in oxidative stress responses, p. 97-112. In R. R. Ruffolo, Jr., G. Z. Feuerstein, A. J. Hunter, G. Poste, and B. W. Metcalf (ed.), Inflammatory cells and mediators in CNS diseases. Harwood Academic Publishers, Amsterdam, The Netherlands.
96. Webster, M. A., J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller. 1998. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
97. Whitman, M., D. R. Kaplan, B. Schaffhausen, L. Cantley, and T. M. Roberts. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-242.
98. Xin, J. H., A. Cowie, P. Lachance, and J. A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:481-496.
99. Yang, B.-S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.
100. Yi, X., J. Peterson, and R. Freund. 1997. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding. J. Virol. 71:6279-6286.
101. Yin, J. J., K. Selander, J. M. Chirgwin, M. Dallas, B. G. Grubbs, R. Wieser, J. Massague, G. R. Mundy, and T. A. Guise. 1999. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Investig. 103:197-206.
102. Yoo, W., M. E. Martin, and W. R. Folk. 1991. PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element. J. Virol. 65:5391-5400.
103. Yordy, J. S., and R. C. Muise-Helmericks. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19:6503-6513.
104. Yoshida, T., and D. Hanahan. 1994. Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am. J. Pathol. 145:671-684.
105. Zhang, G., B. He, and G. F. Weber. 2003. Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer. Mol. Cell. Biol. 23:6507-6519.